An Open-Label, Multicenter Study to Assess the Potential Effects of Ketoconazole on the Pharmacokinetics of Trabectedin in Subjects With Advanced Malignancies.
Phase of Trial: Phase I/II
Latest Information Update: 16 Oct 2015
At a glance
- Drugs Trabectedin (Primary) ; Dexamethasone; Ketoconazole
- Indications Solid tumours
- Focus Pharmacokinetics
- Sponsors Janssen Research & Development
- 15 May 2014 According to the PharmaMar media release, results of this trial presented at 2014 Annual Meeting of American Society of Clinical Oncology.
- 01 Feb 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 09 Jun 2011 Planned End Date changed from 1 Mar 2013 to 1 Apr 2013 as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History